Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Groen

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|November 14, 1997
Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell linesM Bakker, J Renes, A Groenhuijzen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 6, 1998
Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II studyP E Postmus, H Haaxma-Reiche, A Gregor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Single-agent gemcitabine in patients with resistant small-cell lung cancerI van der Lee, E F Smit, J W van Putten, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 29, 2009
TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectivesJ H Stegehuis, L H A M de Wilt, E G E de Vries, et al.
Clinical Pharmacokinetics|March 10, 2001
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolitesT Kerbusch, J de Kraker, H J Keizer, et al.
The European Respiratory Journal|January 12, 2001
A 17-yr old boy with productive cough and progressive dyspnoeaJ E Tulleken, C A van Minnen, T J Waterbolk, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trialP E Postmus, G Scagliotti, H J Groen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observationsP L Jager, H J Groen, A van der Leest, et al.
Cancer|June 22, 1999
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupJ P van Meerbeeck, P Baas, C Debruyne, et al.
The New England Journal of Medicine|July 27, 2000
Preoperative staging of non-small-cell lung cancer with positron-emission tomographyR M Pieterman, J W van Putten, J J Meuzelaar, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|November 14, 1997
Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell linesM Bakker, J Renes, A Groenhuijzen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 6, 1998
Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II studyP E Postmus, H Haaxma-Reiche, A Gregor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Single-agent gemcitabine in patients with resistant small-cell lung cancerI van der Lee, E F Smit, J W van Putten, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 29, 2009
TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectivesJ H Stegehuis, L H A M de Wilt, E G E de Vries, et al.
Clinical Pharmacokinetics|March 10, 2001
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolitesT Kerbusch, J de Kraker, H J Keizer, et al.
The European Respiratory Journal|January 12, 2001
A 17-yr old boy with productive cough and progressive dyspnoeaJ E Tulleken, C A van Minnen, T J Waterbolk, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trialP E Postmus, G Scagliotti, H J Groen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observationsP L Jager, H J Groen, A van der Leest, et al.
Cancer|June 22, 1999
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupJ P van Meerbeeck, P Baas, C Debruyne, et al.
The New England Journal of Medicine|July 27, 2000
Preoperative staging of non-small-cell lung cancer with positron-emission tomographyR M Pieterman, J W van Putten, J J Meuzelaar, et al.
Pageof 8